Global Hepatic Encephalopathy (HE) Therapeutics Market Research Report 2018

SKU ID : QYR- 12137540

Publishing Date : 07-Aug-2018

No. of pages : 95

PRICE
2900
5800

  • This report studies the global Hepatic Encephalopathy (HE) Therapeutics market status and forecast, categorizes the global Hepatic Encephalopathy (HE) Therapeutics market size (value & volume) by key players, type, application, and region. This report focuses on the top players in North America, Europe, Asia-Pacific, South America, and Middle East & Africa.

    HE is a potentially fatal brain disorder that is caused by liver damage, which results in the failure to remove toxins from the blood.
    The availability of patient-focused programs to assist disease management is one of the primary growth drivers for the global hepatic encephalopathy (HE) therapeutics market till 2023. Such programs increase the adherence to therapeutics by improving convenience for patients. Norgine collaborated with the European liver patients association (ELPA) to launch Time to DeLiver program, which is focused on changing the perception about HE among all stakeholders, healthcare professionals, and policymakers. This in turn, drives the demand for diagnosis and management of HE.
    The most commonly used therapeutics to treat HE are lactulose and rifaximin. Researchers are also developing treatments that targets ammonia production and removal. For instance, AST-120 is under investigation and targets gut-derived toxins for liver cirrhosis. It can also be used to treat HE. The progression and development of HE sometimes depends on factors such as inflammation. This is compelling researchers to introduce various treatments that targets inflammation. Some of the most recent approaches to treat HE includes probiotics, albumin administration, and dialysis. Such emergence of novel hepatic encephalopathy treatment targets is identified as one of the key trends that will stimulate growth in the hepatic encephalopathy (HE) therapeutics market during the forecasted period.
    The global Hepatic Encephalopathy (HE) Therapeutics market is valued at xx million US$ in 2017 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2018-2025.

    The major manufacturers covered in this report
    ASKA Pharmaceutical
    COSMO PHARMACEUTICALS
    Mallinckrodt
    Valeant

    Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering
    North America
    Europe
    China
    Japan
    Southeast Asia
    India

    We can also provide the customized separate regional or country-level reports, for the following regions:
    North America
    United States
    Canada
    Mexico
    Asia-Pacific
    China
    India
    Japan
    South Korea
    Australia
    Indonesia
    Singapore
    Rest of Asia-Pacific
    Europe
    Germany
    France
    UK
    Italy
    Spain
    Russia
    Rest of Europe
    Central & South America
    Brazil
    Argentina
    Rest of South America
    Middle East & Africa
    Saudi Arabia
    Turkey
    Rest of Middle East & Africa

    On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Lactulose
    Rifaximin
    Neomycin
    Probiotics
    Thiamine
    On the basis of the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate for each application, including
    Acute Liver Failure
    Portal Systemic Bypass Without Liver Disease
    Liver Cirrhosis

    The study objectives of this report are:
    To analyze and study the global Hepatic Encephalopathy (HE) Therapeutics sales, value, status (2013-2017) and forecast (2018-2025).
    Focuses on the key Hepatic Encephalopathy (HE) Therapeutics manufacturers, to study the sales, value, market share and development plans in future.
    Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
    To define, describe and forecast the market by type, application and region.
    To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
    To identify significant trends and factors driving or inhibiting the market growth.
    To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
    To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
    To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
    To strategically profile the key players and comprehensively analyze their growth strategies.

    In this study, the years considered to estimate the market size of Hepatic Encephalopathy (HE) Therapeutics are as follows:
    History Year: 2013-2017
    Base Year: 2017
    Estimated Year: 2018
    Forecast Year 2018 to 2025

    For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

    Key Stakeholders
    Hepatic Encephalopathy (HE) Therapeutics Manufacturers
    Hepatic Encephalopathy (HE) Therapeutics Distributors/Traders/Wholesalers
    Hepatic Encephalopathy (HE) Therapeutics Subcomponent Manufacturers
    Industry Association
    Downstream Vendors

    Available Customizations
    With the given market data, offers customizations according to the company's specific needs. The following customization options are available for the report:
    Regional and country-level analysis of the Hepatic Encephalopathy (HE) Therapeutics market, by end-use.
    Detailed analysis and profiles of additional market players.

    Frequently Asked Questions



    This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.

    • By product type
    • By End User/Applications
    • By Technology
    • By Region

    The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
    market Reports market Reports